Barry Callebaut has halted manufacturing operations at its Weize chocolate plant in Belgium as a precautionary measure while conducting its root cause analysis and risk assessment after detecting salmonella in a production lot.
The company identified lecithin as the source of the contamination.
All chocolate products manufactured at the facility since June 25 have been placed on hold.
After the analysis, the lines will be cleaned and sanitized before production can resume.
Barry Callebaut, which informed the Belgian food authorities (FAVV) about the incident, said that their robust food safety programs allowed them to identify lecithin as the source of the contamination quickly.
The company added that they are reaching out to all customers who may have received impacted products.
The news comes after Ferrero temporarily suspended production at its Arlon facility in Belgium after the site was linked to a salmonella outbreak.


Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
SK Hynix Joins $1 Trillion Club as AI Chip Demand Fuels Stock Surge
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Costco Q3 Fiscal 2026 Earnings Beat Expectations as Sales and E-Commerce Surge
CDC Confirms U.S. Ebola Case Linked to Congo Outbreak as Travel Restrictions Tighten
US Quantum Stocks Surge After $2 Billion Government Investment
S&P 500, Nasdaq Hit Record Highs as Iran Ceasefire Talks and AI Rally Boost Markets
ECB’s Philip Lane Warns Middle East Conflict Could Keep Inflation Elevated
Salesforce Q1 FY2027 Earnings Beat Expectations Despite Soft Q2 Revenue Outlook
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Oil Prices Jump After New U.S. Strikes on Iran Raise Supply Concerns
Wall Street Hits New Highs as U.S.-Iran Ceasefire Talks Boost Market Sentiment
DOJ Investigates Group Linked to Reid Hoffman Over E. Jean Carroll Lawsuit Funding
Dollar Gains Slightly as U.S.-Iran Tensions Keep Forex Markets on Edge
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
NIO CEO Says China’s Auto Industry Has Passed Its Golden Era Amid Weak Car Sales
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



